Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001567283 | SCV001790939 | likely benign | not provided | 2020-06-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001567283 | SCV002467005 | benign | not provided | 2023-09-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001567283 | SCV004147857 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | TRIOBP: BP4, BP7, BS2 |
Breakthrough Genomics, |
RCV001567283 | SCV005206428 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003948606 | SCV004762227 | benign | TRIOBP-related disorder | 2021-02-03 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |